Shots: The MHLW’s approval is based on stand-alone studies in Japan and global clinical programs and is supported by DIALIZE study that demonstrated the efficacy on Lokelma in treating hyperkalemia […]readmore
Tags : sodium zirconium cyclosilicate
Regulatory
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) Receives NMPA’s Approval for Patients
Shots: The approval is based on four trials assessing Lokelma vs PBO in patients with hyperkalemia treated for up to 12 months The study resulted in a median time of […]readmore
Shots: The P-IIIb DIALIZE study results involve assessing of Lokelma vs PBO in n 196 patients on hemodialysis with hyperkalemia in ESRD The P-IIIb DIALIZE study resulted in maintaining normal […]readmore